Peggy Thompson

Vice President, Head of Biology | San Diego, California, United States

Professional Overview

Peggy Thompson is a seasoned biopharma executive with over 25 years of experience in the pharmaceutical and biotechnology industries. As the Vice President and Head of Biology at Plexium, she is responsible for leading the company's biology and translational research efforts, driving the development of innovative therapies to address unmet medical needs.

Experience Summary

Current Role

As the Vice President and Head of Biology at Plexium since 2020, Peggy oversees all aspects of the company's biology and translational research programs. She is responsible for building and leading a talented team of scientists, establishing strategic research collaborations, and ensuring the efficient progression of Plexium's pipeline. Under her leadership, the company has advanced multiple drug candidates into clinical development, demonstrating her ability to translate scientific discoveries into successful therapeutic programs.

Career Progression

Prior to joining Plexium, Peggy served as the Executive Director of Translational Medicine at eFFECTOR Therapeutics, where she played a key role in advancing the company's pipeline of first-in-class oncology therapies. Before that, she held roles of increasing responsibility at eFFECTOR Therapeutics and Anadys Pharmaceuticals, culminating in her position as Director of Biology. Earlier in her career, Peggy was a Group Leader at Biopraxis, Inc. and a Senior Staff Fellow at the National Institutes of Health, where she conducted groundbreaking research in the field of molecular biology.

Academic Background

Peggy holds a Ph.D. in Molecular Biology from the University of California, San Diego, where she specialized in the study of protein-protein interactions and their role in cellular signaling pathways. Her doctoral work has been published in several peer-reviewed scientific journals, showcasing her strong academic credentials and research expertise.

Areas of Expertise

• Translational medicine and drug discovery

• Molecular and cellular biology

• Oncology and immunology

• Target identification and validation

• Preclinical development and IND-enabling studies

• Cross-functional team leadership and collaboration

Professional Impact

Peggy's contributions to the biopharmaceutical industry have been significant. She has been instrumental in the successful development of multiple drug candidates, including the advancement of several oncology and immunology therapies into clinical trials. Peggy's research has also been recognized by her peers, and she has been invited to present at numerous industry conferences, sharing her insights and driving scientific progress.

Conclusion

With her extensive experience, deep scientific expertise, and proven track record of leading high-performing teams, Peggy Thompson is well-positioned to continue driving innovation and delivering impactful therapies in her role as the Vice President and Head of Biology at Plexium. Her commitment to advancing the field of biopharma and her ability to translate scientific discoveries into tangible clinical outcomes make her a valuable asset to the industry.